0.018129 0.000000 0.000000 0.000000 0.018868 0.000000 0.000000 0.000000 0.012151 0.00000 0.00000 0.00000 Nienaber, V. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 55.160 53.000 82.300 C7 H7 N3 O 149.150 2-AMINO-5-HYDROXY-BENZIMIDAZOLE non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking O4 S -2 96.063 SULFATE ION non-polymer C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Med.Chem. JMCMAR 0151 0022-2623 43 3862 3866 10.1021/jm0002228 11052791 Identification of novel inhibitors of urokinase via NMR-based screening. 2000 US J.Biol.Chem. JBCHA3 0071 0021-9258 275 7239 7248 Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 160 1 IMAGE PLATE RIGAKU RAXIS II SINGLE WAVELENGTH M x-ray 1 1.54 1.0 1.54 ROTATING ANODE RIGAKU 27590.430 UROKINASE 3.4.21.73 B CHAIN (16-243) C122A, N145Q 1 man polymer 96.063 SULFATE ION 1 syn non-polymer 149.150 2-AMINO-5-HYDROXY-BENZIMIDAZOLE 1 syn non-polymer no no IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo fall armyworm Spodoptera sample 9606 Homo sapiens 7108 Spodoptera frugiperda BACULOVIRUS 1 2.18 43.58 VAPOR DIFFUSION, HANGING DROP 0.15M LiSo4, 20% PEG 4000, succinate buffer, VAPOR DIFFUSION, HANGING DROP, temperature 18K 291.0 software exptl_crystal_grow repository Initial release Version format compliance Version format compliance Refinement description Experimental preparation 1 0 2000-10-18 1 1 2008-04-27 1 2 2011-07-13 1 3 2017-10-04 1 4 2018-01-31 _exptl_crystal_grow.temp RCSB Y RCSB 2000-09-19 REL SO4 SULFATE ION 172 2-AMINO-5-HYDROXY-BENZIMIDAZOLE SO4 1 2 SO4 SO4 245 A 172 1 3 172 172 246 A ILE 1 n 1 ILE 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A GLY 4 n 4 GLY 4 A GLU 5 n 5 GLU 5 A PHE 6 n 6 PHE 6 A THR 7 n 7 THR 7 A THR 8 n 8 THR 8 A ILE 9 n 9 ILE 9 A GLU 10 n 10 GLU 10 A ASN 11 n 11 ASN 11 A GLN 12 n 12 GLN 12 A PRO 13 n 13 PRO 13 A TRP 14 n 14 TRP 14 A PHE 15 n 15 PHE 15 A ALA 16 n 16 ALA 16 A ALA 17 n 17 ALA 17 A ILE 18 n 18 ILE 18 A TYR 19 n 19 TYR 19 A ARG 20 n 20 ARG 20 A ARG 21 n 21 ARG 21 A HIS 22 n 22 HIS 22 A ARG 23 n 23 ARG 23 A GLY 23 n 24 A GLY 23 A GLY 24 n 25 GLY 24 A SER 25 n 26 SER 25 A VAL 26 n 27 VAL 26 A THR 27 n 28 THR 27 A TYR 28 n 29 TYR 28 A VAL 29 n 30 VAL 29 A CYS 30 n 31 CYS 30 A GLY 31 n 32 GLY 31 A GLY 32 n 33 GLY 32 A SER 33 n 34 SER 33 A LEU 34 n 35 LEU 34 A MET 35 n 36 MET 35 A SER 36 n 37 SER 36 A PRO 37 n 38 PRO 37 A CYS 38 n 39 CYS 38 A TRP 39 n 40 TRP 39 A VAL 40 n 41 VAL 40 A ILE 41 n 42 ILE 41 A SER 42 n 43 SER 42 A ALA 43 n 44 ALA 43 A THR 44 n 45 THR 44 A HIS 45 n 46 HIS 45 A CYS 46 n 47 CYS 46 A PHE 47 n 48 PHE 47 A ILE 48 n 49 ILE 48 A ASP 49 n 50 ASP 49 A TYR 50 n 51 TYR 50 A PRO 51 n 52 PRO 51 A LYS 52 n 53 LYS 52 A LYS 53 n 54 LYS 53 A GLU 54 n 55 GLU 54 A ASP 55 n 56 ASP 55 A TYR 56 n 57 TYR 56 A ILE 57 n 58 ILE 57 A VAL 58 n 59 VAL 58 A TYR 59 n 60 TYR 59 A LEU 60 n 61 LEU 60 A GLY 61 n 62 GLY 61 A ARG 62 n 63 ARG 62 A SER 63 n 64 SER 63 A ARG 64 n 65 ARG 64 A LEU 65 n 66 LEU 65 A ASN 66 n 67 ASN 66 A SER 67 n 68 SER 67 A ASN 68 n 69 ASN 68 A THR 69 n 70 THR 69 A GLN 70 n 71 GLN 70 A GLY 71 n 72 GLY 71 A GLU 72 n 73 GLU 72 A MET 73 n 74 MET 73 A LYS 74 n 75 LYS 74 A PHE 75 n 76 PHE 75 A GLU 76 n 77 GLU 76 A VAL 77 n 78 VAL 77 A GLU 78 n 79 GLU 78 A ASN 79 n 80 ASN 79 A LEU 80 n 81 LEU 80 A ILE 81 n 82 ILE 81 A LEU 82 n 83 LEU 82 A HIS 83 n 84 HIS 83 A LYS 84 n 85 LYS 84 A ASP 85 n 86 ASP 85 A TYR 86 n 87 TYR 86 A SER 87 n 88 SER 87 A ALA 88 n 89 ALA 88 A ASP 89 n 90 ASP 89 A THR 90 n 91 THR 90 A LEU 91 n 92 LEU 91 A ALA 92 n 93 ALA 92 A HIS 93 n 94 HIS 93 A HIS 94 n 95 HIS 94 A ASN 95 n 96 ASN 95 A ASP 96 n 97 ASP 96 A ILE 97 n 98 ILE 97 A ALA 98 n 99 ALA 98 A LEU 99 n 100 LEU 99 A LEU 100 n 101 LEU 100 A LYS 101 n 102 LYS 101 A ILE 102 n 103 ILE 102 A ARG 103 n 104 ARG 103 A SER 104 n 105 SER 104 A LYS 105 n 106 LYS 105 A GLU 106 n 107 GLU 106 A GLY 107 n 108 GLY 107 A ARG 108 n 109 ARG 108 A CYS 109 n 110 CYS 109 A ALA 110 n 111 ALA 110 A GLN 111 n 112 GLN 111 A PRO 112 n 113 PRO 112 A SER 113 n 114 SER 113 A ARG 114 n 115 ARG 114 A THR 115 n 116 THR 115 A ILE 116 n 117 ILE 116 A GLN 117 n 118 GLN 117 A THR 118 n 119 THR 118 A ILE 119 n 120 ILE 119 A ALA 120 n 121 ALA 120 A LEU 121 n 122 LEU 121 A PRO 122 n 123 PRO 122 A SER 123 n 124 SER 123 A MET 124 n 125 MET 124 A TYR 125 n 126 TYR 125 A ASN 126 n 127 ASN 126 A ASP 127 n 128 ASP 127 A PRO 128 n 129 PRO 128 A GLN 129 n 130 GLN 129 A PHE 130 n 131 PHE 130 A GLY 131 n 132 GLY 131 A THR 132 n 133 THR 132 A SER 133 n 134 SER 133 A CYS 134 n 135 CYS 134 A GLU 135 n 136 GLU 135 A ILE 136 n 137 ILE 136 A THR 137 n 138 THR 137 A GLY 138 n 139 GLY 138 A PHE 139 n 140 PHE 139 A GLY 140 n 141 GLY 140 A LYS 141 n 142 LYS 141 A GLU 142 n 143 GLU 142 A ASN 143 n 144 ASN 143 A SER 144 n 145 SER 144 A THR 145 n 146 THR 145 A ASP 146 n 147 ASP 146 A TYR 147 n 148 TYR 147 A LEU 148 n 149 LEU 148 A TYR 149 n 150 TYR 149 A PRO 150 n 151 PRO 150 A GLU 151 n 152 GLU 151 A GLN 152 n 153 GLN 152 A LEU 153 n 154 LEU 153 A LYS 154 n 155 LYS 154 A MET 155 n 156 MET 155 A THR 156 n 157 THR 156 A VAL 157 n 158 VAL 157 A VAL 158 n 159 VAL 158 A LYS 159 n 160 LYS 159 A LEU 160 n 161 LEU 160 A ILE 161 n 162 ILE 161 A SER 162 n 163 SER 162 A HIS 163 n 164 HIS 163 A ARG 164 n 165 ARG 164 A GLU 165 n 166 GLU 165 A CYS 166 n 167 CYS 166 A GLN 167 n 168 GLN 167 A GLN 168 n 169 GLN 168 A PRO 169 n 170 PRO 169 A HIS 170 n 171 HIS 170 A TYR 171 n 172 TYR 171 A TYR 172 n 173 TYR 172 A GLY 173 n 174 GLY 173 A SER 174 n 175 SER 174 A GLU 175 n 176 GLU 175 A VAL 176 n 177 VAL 176 A THR 177 n 178 THR 177 A THR 178 n 179 THR 178 A LYS 179 n 180 LYS 179 A MET 180 n 181 MET 180 A LEU 181 n 182 LEU 181 A CYS 182 n 183 CYS 182 A ALA 183 n 184 ALA 183 A ALA 184 n 185 ALA 184 A ASP 185 n 186 ASP 185 A PRO 186 n 187 PRO 186 A GLN 187 n 188 GLN 187 A TRP 188 n 189 TRP 188 A LYS 189 n 190 LYS 189 A THR 190 n 191 THR 190 A ASP 191 n 192 ASP 191 A SER 192 n 193 SER 192 A CYS 193 n 194 CYS 193 A GLN 194 n 195 GLN 194 A GLY 195 n 196 GLY 195 A ASP 196 n 197 ASP 196 A SER 197 n 198 SER 197 A GLY 198 n 199 GLY 198 A GLY 199 n 200 GLY 199 A PRO 200 n 201 PRO 200 A LEU 201 n 202 LEU 201 A VAL 202 n 203 VAL 202 A CYS 203 n 204 CYS 203 A SER 204 n 205 SER 204 A LEU 205 n 206 LEU 205 A GLN 206 n 207 GLN 206 A GLY 207 n 208 GLY 207 A ARG 208 n 209 ARG 208 A MET 209 n 210 MET 209 A THR 210 n 211 THR 210 A LEU 211 n 212 LEU 211 A THR 212 n 213 THR 212 A GLY 213 n 214 GLY 213 A ILE 214 n 215 ILE 214 A VAL 215 n 216 VAL 215 A SER 216 n 217 SER 216 A TRP 217 n 218 TRP 217 A GLY 218 n 219 GLY 218 A ARG 219 n 220 ARG 219 A GLY 220 n 221 GLY 220 A CYS 221 n 222 CYS 221 A ALA 222 n 223 ALA 222 A LEU 223 n 224 LEU 223 A LYS 224 n 225 LYS 224 A ASP 225 n 226 ASP 225 A LYS 226 n 227 LYS 226 A PRO 227 n 228 PRO 227 A GLY 228 n 229 GLY 228 A VAL 229 n 230 VAL 229 A TYR 230 n 231 TYR 230 A THR 231 n 232 THR 231 A ARG 232 n 233 ARG 232 A VAL 233 n 234 VAL 233 A SER 234 n 235 SER 234 A HIS 235 n 236 HIS 235 A PHE 236 n 237 PHE 236 A LEU 237 n 238 LEU 237 A PRO 238 n 239 PRO 238 A TRP 239 n 240 TRP 239 A ILE 240 n 241 ILE 240 A ARG 241 n 242 ARG 241 A SER 242 n 243 SER 242 A HIS 243 n 244 HIS 243 A THR 244 n 245 THR 244 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O GLU 5 A O GLU 5 A N MET 155 A N MET 156 A O VAL 158 A O VAL 159 A N CYS 134 A N CYS 135 A O CYS 30 A O CYS 31 A N ILE 18 A N ILE 18 A N TYR 19 A N TYR 19 A O ILE 57 A O ILE 58 A O LEU 60 A O LEU 61 A N MET 73 A N MET 74 A N ILE 81 A N ILE 82 A O LEU 99 A O LEU 100 A N LEU 100 A N LEU 101 A O VAL 40 A O VAL 41 A N ILE 41 A N ILE 42 A O SER 33 A O SER 34 A O SER 87 A O SER 88 A N HIS 94 A N HIS 95 A O ALA 183 A O ALA 184 A N GLY 228 A N GLY 229 A N THR 231 A N THR 232 A O ILE 214 A O ILE 215 A O GLY 213 A O GLY 214 A N LEU 201 A N LEU 202 1 A LYS 53 -14.40 1 A A SER VAL 25 26 -149.41 1 A A PRO GLN 186 187 -129.31 1 A TYR 56 0.081 SIDE CHAIN 1 3.93 0.50 120.30 124.23 A A A NE CZ NH1 ARG ARG ARG 21 21 21 N 1 -3.80 0.50 120.30 116.50 A A A NE CZ NH2 ARG ARG ARG 21 21 21 N 1 3.09 0.50 120.30 123.39 A A A NE CZ NH1 ARG ARG ARG 23 23 23 N 1 -3.76 0.50 120.30 116.54 A A A NE CZ NH2 ARG ARG ARG 23 23 23 N 1 7.48 1.10 114.20 121.68 A A A CA CB SG CYS CYS CYS 30 30 30 N 1 -16.25 2.70 111.00 94.75 A A A N CA C SER SER SER 36 36 36 N 1 15.27 1.10 114.20 129.47 A A A CA CB SG CYS CYS CYS 46 46 46 N 1 16.57 2.20 113.40 129.97 A A A CA CB CG ASP ASP ASP 55 55 55 N 1 4.94 0.50 120.30 125.24 A A A NE CZ NH1 ARG ARG ARG 62 62 62 N 1 -5.87 0.50 120.30 114.43 A A A NE CZ NH2 ARG ARG ARG 62 62 62 N 1 24.14 2.70 111.20 135.34 A A A CA CB OG SER SER SER 63 63 63 N 1 17.38 2.70 111.00 128.38 A A A N CA C GLN GLN GLN 70 70 70 N 1 28.77 2.30 115.30 144.07 A A A CA CB CG LEU LEU LEU 91 91 91 N 1 -12.16 1.70 111.00 98.84 A A A CB CG CD1 LEU LEU LEU 91 91 91 N 1 11.24 1.70 111.00 122.24 A A A CB CG CD2 LEU LEU LEU 91 91 91 N 1 16.60 2.70 111.00 127.60 A A A N CA C ALA ALA ALA 92 92 92 N 1 10.29 0.90 118.30 128.59 A A A CB CG OD1 ASP ASP ASP 96 96 96 N 1 -9.40 0.90 118.30 108.90 A A A CB CG OD2 ASP ASP ASP 96 96 96 N 1 -11.11 1.80 114.00 102.89 A A A CA CB SG CYS CYS CYS 109 109 109 N 1 15.24 2.50 121.70 136.94 A A A C N CA SER ARG ARG 113 114 114 Y 1 3.82 0.50 120.30 124.12 A A A NE CZ NH1 ARG ARG ARG 114 114 114 N 1 -3.47 0.50 120.30 116.83 A A A NE CZ NH2 ARG ARG ARG 114 114 114 N 1 14.30 2.20 113.40 127.70 A A A CA CB CG ASN ASN ASN 143 143 143 N 1 -19.61 2.70 111.00 91.39 A A A N CA C MET MET MET 180 180 180 N 1 14.57 2.30 115.30 129.87 A A A CA CB CG LEU LEU LEU 181 181 181 N 1 17.90 2.70 111.00 128.90 A A A N CA C GLN GLN GLN 187 187 187 N 1 17.64 2.70 111.00 128.64 A A A N CA C LYS LYS LYS 189 189 189 N 1 18.71 2.20 113.40 132.11 A A A CA CB CG ASP ASP ASP 196 196 196 N 1 -8.08 0.90 118.30 110.22 A A A CB CG OD1 ASP ASP ASP 196 196 196 N 1 5.25 0.50 120.30 125.55 A A A NE CZ NH1 ARG ARG ARG 208 208 208 N 1 -5.36 0.50 120.30 114.94 A A A NE CZ NH2 ARG ARG ARG 208 208 208 N 1 4.30 0.50 120.30 124.60 A A A NE CZ NH1 ARG ARG ARG 219 219 219 N 1 -4.89 0.50 120.30 115.41 A A A NE CZ NH2 ARG ARG ARG 219 219 219 N 1 9.63 0.90 118.30 127.93 A A A CB CG OD1 ASP ASP ASP 225 225 225 N 1 -10.16 0.90 118.30 108.14 A A A CB CG OD2 ASP ASP ASP 225 225 225 N 1 4.88 0.50 120.30 125.18 A A A NE CZ NH1 ARG ARG ARG 241 241 241 N 1 -3.96 0.50 120.30 116.34 A A A NE CZ NH2 ARG ARG ARG 241 241 241 N 1 A A CB OG SER SER 33 33 0.087 0.013 1.418 1.505 N 1 A A CG CD GLU GLU 78 78 0.091 0.015 1.515 1.606 N 1 A A CB OG SER SER 197 197 -0.087 0.013 1.418 1.331 N 1 A A NE CZ ARG ARG 241 241 0.086 0.013 1.326 1.412 N 1 A ARG 23 -64.79 99.35 1 A SER 25 69.81 -155.49 1 A VAL 29 -87.42 -70.29 1 A SER 36 -178.44 147.04 1 A SER 42 -164.09 -154.81 1 A GLU 54 -56.98 -9.47 1 A LEU 65 -25.72 -43.57 1 A ASN 66 -141.48 38.41 1 A GLN 70 -51.56 94.51 1 A LYS 84 -47.95 -6.34 1 A LEU 91 79.01 -66.19 1 A ASN 95 39.98 62.18 1 A ARG 103 177.85 110.28 1 A CYS 109 -53.96 175.09 1 A SER 113 -79.62 -137.69 1 A ILE 116 -152.80 80.64 1 A TYR 125 23.72 54.19 1 A CYS 134 -119.27 -166.67 1 A TYR 171 -93.73 -105.72 1 A ALA 183 -171.83 144.19 1 A GLN 187 -31.79 159.85 1 A TRP 188 81.69 -22.78 1 A ASP 191 174.81 178.02 1 A CYS 193 -177.01 -159.61 1 A GLN 206 72.84 -20.14 1 A LEU 211 -64.12 73.18 1 A SER 216 -129.81 -56.72 1 A ALA 222 76.69 46.97 1 A LYS 224 -56.58 109.33 1 A ASP 225 95.54 2.18 11.3 0.00 0.00 0.00 0.00 0.00 0.00 0.248 0.248 3.00 10.00 2625 RANDOM 10000000.00 0.00 1 RESTRAINED 2.0 0.35 5.00 0.27 3.00 10.00 0 1949 16 0 1933 0.026 3.5 28.9 2.35 1.67 1.50 2.48 2.00 2.74 2.00 4.04 2.50 0.251 3.18 460 6 data scaling SCALEPACK phasing AMoRE refinement X-PLOR 98.0 UROKINASE (E.C.3.4.21.73) Crystal structure of human microurokinase in complex with 2-amino-5-hydroxy-benzimidazole 1 N N 2 N N 3 N N A THR 8 A THR 8 HELX_P A GLN 12 A GLN 12 5 1 5 A ALA 43 A ALA 44 HELX_P A PHE 47 A PHE 48 5 2 5 A LYS 52 A LYS 53 HELX_P A GLU 54 A GLU 55 5 3 3 A SER 162 A SER 163 HELX_P A GLN 167 A GLN 168 1 4 6 A TYR 172 A TYR 173 HELX_P A VAL 176 A VAL 177 5 5 5 A PHE 236 A PHE 237 HELX_P A SER 242 A SER 243 1 6 7 disulf 1.954 A CYS 30 A SG CYS 31 1_555 A CYS 46 A SG CYS 47 1_555 disulf 2.006 A CYS 38 A SG CYS 39 1_555 A CYS 109 A SG CYS 110 1_555 disulf 2.010 A CYS 134 A SG CYS 135 1_555 A CYS 203 A SG CYS 204 1_555 disulf 2.036 A CYS 166 A SG CYS 167 1_555 A CYS 182 A SG CYS 183 1_555 disulf 2.021 A CYS 193 A SG CYS 194 1_555 A CYS 221 A SG CYS 222 1_555 BLOOD CLOTTING Plasminogen activation, BLOOD CLOTTING UROK_HUMAN UNP 1 179 P00749 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT 179 423 1FV9 1 244 P00749 A 1 1 245 1 CYS CONFLICT ALA 120 1FV9 A P00749 UNP 299 121 3 7 2 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 5 A GLU 5 A PHE 6 A PHE 6 A LYS 154 A LYS 155 A LYS 159 A LYS 160 A SER 133 A SER 134 A GLY 138 A GLY 139 A SER 25 A SER 26 A CYS 30 A CYS 31 A ALA 17 A ALA 17 A HIS 22 A HIS 22 A TYR 56 A TYR 57 A LEU 60 A LEU 61 A MET 73 A MET 74 A LEU 82 A LEU 83 A ALA 98 A ALA 99 A ARG 103 A ARG 104 A TRP 39 A TRP 40 A SER 42 A SER 43 A SER 33 A SER 34 A SER 36 A SER 37 A SER 87 A SER 88 A ALA 88 A ALA 89 A HIS 93 A HIS 94 A HIS 94 A HIS 95 A MET 180 A MET 181 A ALA 183 A ALA 184 A LYS 226 A LYS 227 A ARG 232 A ARG 233 A ARG 208 A ARG 209 A LEU 223 A LEU 224 A PRO 200 A PRO 201 A LEU 205 A LEU 206 BINDING SITE FOR RESIDUE SO4 A 245 Software 5 BINDING SITE FOR RESIDUE 172 A 246 Software 9 A HIS 45 A HIS 46 5 1_555 A GLN 194 A GLN 195 5 1_555 A GLY 195 A GLY 196 5 1_555 A SER 197 A SER 198 5 1_555 A 172 246 C 172 5 1_555 A ASP 191 A ASP 192 9 1_555 A SER 192 A SER 193 9 1_555 A CYS 193 A CYS 194 9 1_555 A GLN 194 A GLN 195 9 1_555 A VAL 215 A VAL 216 9 1_555 A GLY 218 A GLY 219 9 1_555 A GLY 220 A GLY 221 9 1_555 A GLY 228 A GLY 229 9 1_555 A SO4 245 B SO4 9 1_555 19 P 21 21 21